UnitedHealth Beat Sparks Standout Rally Across Health Care

The Health Care Select Sector SPDR Fund, an exchange-traded fund that tracks the sector under the ticker XLV, closed +2.5% on Wednesday, October 14. EasyAlpha grades the stocks in the sector against their industry peers, and 51.8% of the fund's weight sits in companies graded A or B. Internally, 78.9% of the sector's stocks moved higher, but the advance was driven primarily by its largest component. UnitedHealth Group Incorporated closed +4.8%, lifting the cap-weighted sector move to +2.5% while the equal-weighted sector move finished at +1.3%. That heavyweight outperformance followed a third-quarter regulatory filing in which the company reported third-quarter results and raised its full-year adjusted earnings guidance to at least $20.50 per share. The report drew reiterated positive analyst coverage that supported the stock.

Health care was a rare pocket of strength in the broader market, where 3 of the 11 sectors rose. Moderna Inc was among the day's top gainers, closing +4.6%. Positive sentiment extended through several therapeutic areas as Amgen found support from pipeline momentum. Collaboration also supported the group, with Gilead entering an oncology research agreement. Meanwhile, AbbVie advanced following positive Phase 3 clinical data for its subcutaneous Crohn's disease treatment.

The rally did not reach every corner of the sector. Medical equipment maker Insulet Corporation was the session's primary laggard, finishing -3.0%, though our sources show no reported driver for the move.

At an expense ratio of 0.08%, the fund keeps annual holding costs low across its $43.4 billion portfolio. Following Wednesday's close at $173.93, the exchange-traded fund has preserved an extended upward trajectory, standing at +22.2% over the past twelve months.